Home › Products › Oncology › Abiralieva 250mg Tablet
Abiralieva 250mg Tablet
Salt Composition: ABIRATERONE ACETATE
- Manufacturer: Allieva Pharma Pvt. Ltd.
- Pack Size: 120 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 250MG
- Prescription Required
₹4542.00₹26718.00
Inclusive of all taxes
Product Introduction
Abiralieva 250mg Tablet is used in adult men for treatment of prostate cancer that has spread to other parts of the body. Abiralieva 250mg Tablet stops the body's production of testosterone, which slows down the growth of prostate cancer. Abiralieva 250mg Tablet is prescribed in early stage disease where it still responds to hormone therapy.
Patients should inform their physician or pharmacist if they have liver problems, high blood pressure or heart failure, or low blood potassium, as it may increase the risk of heart rhythm problems, heart or blood vessel related problems, irregular or fast heart rate, shortness of breath, rapid weight gain, swelling in feet, ankles or legs, possible effects on bones, high blood sugar, or any heart or blood vessel conditions including irregularities in heart rhythm or concurrent treatment with medicines for these conditions.
Signs of liver problems include yellow skin or eyes, dark urine, nausea and vomiting. Very rarely liver failure occurs that leads to death.
Abiralieva 250mg Tablet is not used in children and adolescents. In case of accidental ingestion, take the patient along with the package leaflet to the doctor on an emergency basis.
Serious side effects include muscle weakness, muscle twitching and palpitation. These are signs of low potassium in blood. Decrease in red blood cells and reduced sex drive occur with intake of Abiralieva 250mg Tablet.
Abiralieva 250mg Tablet must never be taken with Ra-223, which is used to treat prostate cancer.
Uses
Abiralieva 250mg Tablet is used in the treatment of prostate cancer .
How it works
The drug works by inhibiting the production of testosterone by the body. This can slow the growth of prostate cancer.
How to Use
The medicine should always be consumed as per the direction of your physician or pharmacist. The medicine should be taken by mouth. It should not be taken with food. Swallow the tablets whole with water without breaking them. The medicine should be taken with prednisone or prednisolone every day while you are taking Abiralieva 250mg Tablet. The amount of prednisone or prednisolone will be as per doctorâs advice. The discontinuation of prednisone or prednisolone will also be as per doctorâs advice. If more than one Abiralieva 250mg Tablet is consumed the patient should inform the doctor.
Side Effects
Serious: Muscle weakness. Muscle twitches Palpitations Lung irritation Failure of liver to function Adrenal gland problems Abnormal heart rhythm Heart attack Changes in the electrocardiogram Serious allergic reactions with difficulty in swallowing or breathing. Swollen face, lips, tongue, or throat Itchy rash. Bone loss. Common Fluid in legs or feet. Low blood potassium Liver function test increases High blood pressure Urinary tract infection Diarrhea High fat levels in the blood Chest pain Irregular heart beat Heart failure Rapid heart rate Severe infections. Bone fracture Indigestion Blood in urine Rash
Expert Tips
Inform the doctor if the patient has any liver, blood pressure, heart disorders, diabetes and medication taken for different medical conditions before taking this medication. The medicine should be taken as prescribed by the doctor. This medication should be taken orally and it should be taken in an empty stomach. It should not be taken with food and swallow the tablet as a whole with water without breaking them. Food must be eaten at least 2 hours before taking the medication and the patient is advised to eat after 1hr after consuming the medication. Blood pressure, potassium levels, liver function tests should be monitored regularly while taking this medication.
References
- Centocor Ortho Biotech Inc, US Food and drug administration, [ Revised date: APR 2011] [ Accessed date: 02nd APR 2021] https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202379lbl.pdf
- Janssen- Cilag International NV, Electronics Medicine Compendium, [ Revised date: DEC 2020] [ Accessed date: 02nd APR 2021] https://www.medicines.org.uk/emc/files/pil.2381.pdf
Safety Advice
Pregnancy: Consult Doctor
Lungs: Consult Doctor
Breastfeeding: Consult Doctor
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.